IP Library Granted Patent US 12,478,082
Granted Patent B2
US 12,478,082 · App. 18/467,362 · Granted Nov 25, 2025

Uridine diphosphate-dependent glycosyltransferase enzyme

Inventors: Ryan Philippe (Waltham, MA); Ajikumar Parayil Kumaran (Waltham, MA); Jason Donald (Waltham, MA); Krishna Patel (Waltham, MA); Swati Gupta (Waltham, MA); Ryan Lim (Waltham, MA); Liwei Li (Waltham, MA)
Assignee: Manus Bio Inc.
A23L2/60A23L27/36C12N9/0073C12N9/1048C12N9/1051C12P19/56C12Y114/13079C12Y204/01017A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,478,082
App. No.
18/467,362
Granted
Nov 25, 2025
Kind
B2
Abstract

The invention provides methods for making steviol glycosides, including RebM and glycosylation products that are minor products in stevia leaves, and provides enzymes, encoding polynucleotides, and host cells for use in these methods. The invention provides engineered enzymes and engineered host cells for producing steviol glycosylation products, such as RebM, at high purity and/or yield. The invention further provides methods of making products containing steviol glycosides, such as RebM, including food products, beverages, oral care products, sweeteners, and flavoring products.

Claims (15)

1 . A method for making rebaudioside M comprising: culturing a host cell in the presence of rebaudioside D, the host cell expressing a uridine diphosphate-dependent glycosyltransferase (UGT) enzyme comprising an amino acid sequence that has at least 90% sequence identity to SEQ ID NO: 3 and has a L200A or L200G substitution with respect to SEQ ID NO: 3.

2 . The method of claim 1 , wherein the UGT enzyme comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 3.

3 . The method of claim 1 , wherein the UGT enzyme comprises an amino acid having at least 97% sequence identity to SEQ ID NO: 3.

4 . The method of claim 1 , wherein the UGT enzyme comprises an amino acid sequence having at least 98% sequence identity to SEQ ID NO: 3.

5 . The method of claim 1 , wherein the UGT enzyme comprises an amino acid sequence having at least 99% sequence identity to SEQ ID NO: 3.

6 . The method of claim 1 , wherein the UGT enzyme further comprises T284A substitution with respect to SEQ ID NO: 3.

7 . The method of claim 1 , wherein the host cell further expresses a UT enzyme comprising an amino acid sequence having at least 90% sequence identity to an amino acid sequence selected from: SEQ ID NO: 7, SEQ ID NO: 5, SEQ ID NO: 4, SEQ ID NO: 6, and SEQ ID NO: 45.

8 . The method of claim 7 , wherein the host cell further expresses a UGT enzyme comprising an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 1, and a UGT enzyme comprising an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 2.

9 . The method of claim 1 , wherein the host cell is prokaryotic.

10 . The method of claim 9 , wherein the host cell is a bacterial cell selected from E. coli, Bacillus subtillus , or Pseudomonas putida.

11 . The method of claim 1 , wherein the host cell is Saccharomyces cerevisiae, Pichia pastoris , or Yarrowia lipolytica.

12 . The method of claim 1 , wherein the host cell further comprises one or more genetic modifications increasing the availability of UDP-glucose.

13 . The method of claim 1 , wherein the UGT enzyme further comprises one or more amino acid modifications with respect to SEQ ID NO: 3 selected from: S77A, N78A, T81A, insertion of G after amino acid 194, T284A, and L379A.

14 . A method for making rebaudioside M comprising: culturing a host cell in the presence of rebaudioside D, the host cell expressing a uridine diphosphate-dependent glycosyltransferase (UGT) enzyme comprising an amino acid sequence that has at least 90% sequence identity to SEO ID NO: 3 and has one or more amino acid modifications with respect to SEO ID NO: 3 selected from: S77A, N78A, T81A, insertion of G after amino acid 194, L200A, L200G, T284A, and L379A, wherein the UGT enzyme comprises an Ala inserted or substituted at position 2, with respect to SEQ ID NO: 3.

15 . A method for making rebaudioside M comprising: culturing a host cell in the presence of rebaudioside D, the host cell expressing a uridine diphosphate-dependent glycosyltransferase (UGT) enzyme comprising an amino acid sequence that has at least 90% sequence identity to SEO ID NO: 3 and has one or more amino acid modifications with respect to SEO ID NO: 3 selected from: S77A, N78A, T81A, insertion of G after amino acid 194, L200A, L200G, T284A, and L379A, wherein the host cell further comprises one or more genetic modifications increasing the availability of UDP-glycose, wherein the host cell is E. coli comprising one or more genetic modifications selected from ΔgalE, ΔgalT, ΔgalK, ΔgalM, ΔushA, Δagp, Δpgm, duplication of E. coli GALU, and expression of Bacillus substillus UGPA, BaSP.

Assignments (1)
SECURITY INTEREST Recorded Sep 8, 2025
From: MANUS BIO INC.; STO.PERU I LLC; STO.PERU II LLC; MANUS INTERMEDIATE INC.; MANUS INSCRIPTA, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 072836/0255 →
Continuity (5)
Continuation 16862214 · Apr 29, 2020
Continuation 16251993 · Jan 18, 2019
Division 15524015
Provisional Application 62075644 · Nov 5, 2014
Related Publication 20240215615A1 · Jul 4, 2024
References Cited (25)
US 8703225B2 · Morita et al. · 2014 [cited by applicant]
US 9243273B2 · Markosyan et al. · 2016 [cited by applicant]
US 9562251B2 · Kishore et al. · 2017 [cited by applicant]
US 9848632B2 · Morita et al. · 2017 [cited by applicant]
US 9957540B2 · Mikkelsen et al. · 2018 [cited by applicant]
US 10463062B2 · Philippe et al. · 2019 [cited by applicant]
US 20080064063A1 · Brandle et al. · 2008 [cited by applicant]
US 20140357588A1 · Markosyan et al. · 2014 [cited by applicant]
US 20160186225A1 · Mikkelsen · 2016 [cited by examiner]
US 20160198748A1 · Prakash · 2016 [cited by examiner]
US 20170275666A1 · Prakash · 2017 [cited by examiner]
US 20230279459A1 · Dalgaard Mikkelsen · 2023 [cited by examiner]
JP 3277275 · 1991 [cited by applicant]
WO 2011153378 · 2011 [cited by applicant]
WO 2012075030 · 2012 [cited by applicant]
WO 2013022989 · 2013 [cited by applicant]
WO 2014122227 · 2014 [cited by applicant]
International Search Report and Written Opinion, International Application No. PCT/US2015/059273, dated Mar. 30, 2016, 10 pages. [cited by applicant]
Ohta, et al., “Characterization of Novel Steviol Glycosides from Leaves of Stevia rebaudiana Morita”, J. Appl. Glycosci., 2010 57, pp. 199-209. [cited by applicant]
Brandle, et al., “Steviol glycoside biosynthesis”, Phytochemistry, 2007, vol. 68, pp. 1855-1863. [cited by applicant]
Richman et al., Functional genomics uncovers three glucosyltransferases involved in the synthesis of the major sweet glucosides of Stevia rebaudiana, The Plant Journal, 2005 vol. 41, pp. 56-67. [cited by applicant]
Li et al., “Phylogenetic Analysis of the UDP-glycosyltransferase Multigene Family of [cited by applicant]
Shibata et al., Glucosylation of Steviol and Steviol-Glucosides in Extracts from Stevia rebaudiana Bertoni, Plant Physiol., 1991, vol. 95, pp. 152-156. [cited by applicant]
Lim, et al., The Activity of Arabidopsis Glycosyltransferases toward Salicylic Acid, 4-Hydroxybenzoic Acid, and Other Benzoates, 2002, The Journal of Biological Chemistry, vol. 277, No. 1, pp. 586-592. [cited by applicant]
Ko, et al., “Glycosylation of Flavonoids with a Glycosyltransferase from Bacillus cereus,” FEMS Microbiol Lett, 2006, vol. 258, pp. 263-268. [cited by applicant]